Tracking IV clot-busting treatment for stroke in China
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is tracking patients in southwestern China who have had an acute ischemic stroke and received a clot-busting medicine through an IV. It aims to learn more about how well this treatment works and how it is used in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with an acute ischemic stroke (a stroke caused by a blood clot).
- You must have received a clot-dissolving medicine through an IV (intravenous thrombolysis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information on stroke patients who received the clot-dissolving drug tenecteplase. It aims to see how well the drug works and how safe it is in everyday hospital care in China.
This study tracks patients who receive IV thrombolysis (a clot-busting medication injected into the vein) for acute ischemic stroke more than 4.5 hours after their stroke started. Researchers want to learn whether this extended-window treatment can still help patients recover when given outside the typical time window.
This trial tests if a clot-dissolving medicine can help people who had a mild ischemic stroke and also had a prior stroke in the last 3 months. It aims to see if the treatment is safe and effective for this specific group.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This trial tests whether clot-busting drugs or mechanical clot removal given within 24 hours of a minor ischemic stroke is safe and effective. It aims to find the best way to restore blood flow to the brain for people with mild symptoms.
This study looks at whether giving a clot-busting medicine (IV thrombolysis) is safe and effective for people who have had a stroke and also recently took a direct oral anticoagulant (DOAC). If you've taken a DOAC in the last 48 hours, this trial may help doctors decide the best treatment for you.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.